SORTIVA 50mg price in UAE

Overview

Welcome to Dwaey, specifically on SORTIVA 50mg Tablets/Film-coated page.
This medicine contains an important and useful components, as it consists of Losartan potassium.
SORTIVA 50mg is available in the market in concentration 50mg/Tablet and in the form of Tablets/Film-coated.

SPIMACO (AL QASSIM PHARMACEUTICAL PLANT) is the producer of SORTIVA 50mg and it is imported from SAUDI ARABIA, The most popular alternatives of SORTIVA 50mg are listed downward .

Mode Of Action

Losartan is an angiotensin II receptor antagonist. It selectively and competitively blocks the vasoconstricting and aldosterone-secreting effects of angiotensin II by selectively antagonising its binding to AT1 receptors.

Indication

Diabetic nephropathy
Hypertension
Stroke risk reduction of hypertensive or LVH patients
Heart Failure
Hypertensive Patients with Left Ventricular Hypertrophy

Precaution

Volume-depleted patients including patients on high-dose diuretics. Patients w/ bilateral renal artery stenosis , aortic or mitral stenosis. Renal and mild to moderate hepatic impairment. Lactation. Monitoring Parameters Monitor BP, electrolytes and renal function. Lactation: Unknown if excreted in milk; not recommended

Side Effects

>10% Fatigue (14%)
Hypoglycemia (14%)
Anemia (14%)
Urinary tract infection (UTI) (13%)
Chest pain (12%)
Weakness (14%)
Diarrhea (2-15%)
Cough; incidence higher in previous cough related to angiotensin-converting enzyme (ACE) inhibitor therapy (3-11%) 1-10% Upper respiratory tract infection (8%)
Hypotension (7%)
Dizziness (4%)
Cellulitis (7%)
Gastritis (5%)
Nausea (2%) Frequency Not Defined Angioedema
Edema/swelling
Hypotension in hypovolemic or diuretic-using patients
Asthenia
Headache
Malaise
Nausea
Abdominal pain
Hyperkalemia
Back pain
Worsening renal failure

Contra indication

Losartan potassium is contraindicated in patients who are hypersensitive to the active ingredient or any component of the drug. Concomitant use w/ aliskiren in patients w/ diabetes and renal impairment (GFR <60 mL/min). Severe hepatic impairment. Pregnancy.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Pregnancy Categories C (first trimester) and D (second and third trimesters).

Interaction

May decrease plasma levels / fluconazole and rifampicin. May increase serum lithium levels and toxicity. May antagonise hypotensive effect and increase risk of renal impairment w/ NSAIDs. Increased risk of hyperkalaemia w/ K-sparing diuretics (e.g. amiloride, triamterene, spironolactone), K supplements or K-containing salt substitutes. Potentially Fatal: May increase nephrotoxic, hyperkalaemic and hypotensive effect w/ aliskiren in patients w/ diabetes and renal impairment (GFR <60 mL/min).